STOCK TITAN
  1. Home
  2. PNT

Point Biopharma Global Stock Price, News & Analysis

PNT NASDAQ

Company Description

Point Biopharma Global (NASDAQ: PNT) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector.

PNT stock has declined 100.0% over the past year.

This page provides a comprehensive overview of PNT stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
-100%
Performance 1 year
$0.0
Market Cap
106.6M
Shares outstanding

Point Biopharma Global (PNT) stock. Over the past 12 months, the stock has lost 100.0%.

Latest News

View All
January 8, 2024
0.00%

Domain Therapeutics Strengthens Leadership Team to Spearhead Global Development and North American Expansion as the Leading GPCR Immuno-Oncology Company

management
December 27, 2023
0.00%

Lilly Completes Acquisition of POINT Biopharma

acquisition
December 18, 2023
-11.20%

Lantheus and POINT Biopharma Announce Positive Topline Results from Pivotal SPLASH Trial in Metastatic Castration-Resistant Prostate Cancer

clinical trial
December 18, 2023
-11.20%

Lilly Extends Tender Offer to Acquire POINT Biopharma to Dec. 22, 2023

acquisition
December 4, 2023
-0.36%

Lilly Extends Tender Offer to Acquire POINT Biopharma to Dec. 15, 2023

acquisition
November 17, 2023
+2.63%

Lilly Extends Tender Offer to Acquire POINT Biopharma to Dec. 1, 2023

acquisition

Point Biopharma Global has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 3 with negative movement. Key topics include management, acquisition, clinical trial, earnings. View all PNT news →

SEC Filings

View All

No SEC filings available for PNT.

Financial Highlights

View Full Financials
—
Revenue (TTM)
—
Net Income (TTM)
—
Diluted EPS (TTM)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

PNT Company Profile & Sector Positioning

Point Biopharma Global (PNT) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.